Clinically, elevated HOST2 expression has been associated with advanced tumor stage, lymph node or distant metastasis, and unfavorable overall survival in several cancer types, suggesting potential value as a prognostic biomarker and therapeutic target.
Qian-Wen Du, Ling-Yun Zhou, Dan Song et al.· Current molecular medicine· 0 citations
AIM
To clarify the concept of healthcare-seeking decision-making of individuals with mild cognitive impairment, through the identification of its defining attributes, antecedents, and consequences.
DESIGN
Concept analysis guided by the Walker and Avant methodology.
METHODS
Nine databases (PubMed, Web of Science, CI...
Yu-Na Li, Ting-He Luo, Qing Wang et al.· Geriatric Nursing· 0 citations
Malignant tumors remain a leading cause of global mortality, and the development of chemoresistance represents a major obstacle to effective cancer treatment. Long non-coding RNAs (lncRNAs) are important regulators of tumor progression and therapeutic response. Cancer susceptibility candidate 2 (CASC2) is an lncRNA tha...
Ling-Yun Zhou, Jin-Tao He, Wen-Bing Huang et al.· Journal of chemotherapy· 0 citations
GAS6-AS1 represents a promising molecule for understanding cancer pathogenesis and developing novel strategies for precision cancer diagnosis and treatment, although further clinical validation and mechanistic studies are still required.
Zhi-Ling Lu, Wen-Bing Huang, Jin-Tao He et al.· Biomedical Reports· 0 citations
Findings identify ADRB2 as a potential diagnostic and mechanistic target in asbestos-related PM and suggest that ADRB2 may contribute to crocidolite-induced malignant progression by modulating cellular responses associated with IL-17/NF-κB-related inflammatory signalling.
Shaoyang Huang, Dandan Gu, Jin-Tao He et al.· Chemico-Biological Interacti...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.